Rxivist logo

Author: Warren Kalina

  • Most recently observed institution: Vaccine Research and Development, Pfizer, Inc.

Rankings

  • All-time downloads: 155,757 (rank: 508 )
  • Categories:
    • infectious diseases: 155,757 (rank: 107 (tie) )

Downloads per author, site-wide

Preprints

Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report

infectious diseases more details view paper
  • Downloaded 68,181 times
  • Download rankings, all-time:
    • Site-wide: 77
    • In infectious diseases: 30
  • Year to date:
    • Site-wide: 203
  • Since beginning of last month:
    • Site-wide: 232

RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study

infectious diseases more details view paper
  • Downloaded 64,715 times
  • Download rankings, all-time:
    • Site-wide: 82
    • In infectious diseases: 32
  • Year to date:
    • Site-wide: 80
  • Since beginning of last month:
    • Site-wide: 167

Concurrent human antibody andTH1 type T-cell responses elicited by a COVID-19 RNA vaccine

infectious diseases more details view paper
  • Downloaded 22,861 times
  • Download rankings, all-time:
    • Site-wide: 302
    • In infectious diseases: 113
  • Year to date:
    • Site-wide: 461
  • Since beginning of last month:
    • Site-wide: 683

PanLingua

News